Simplex Trading
AMLX icon

Simplex Trading’s Amylyx Pharmaceuticals AMLX Stock Holding History

Simplex Trading’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165K Buy
11,900
+9,200
+341% +$129K ﹤0.01% 4528
2025
Q4 		$32.6K Sell
2,700
-6,900
-72% -$93.7K ﹤0.01% 6039
2025
Q3 		$130K Buy
9,600
+8,000
+500% +$75.3K ﹤0.01% 5449
2025
Q2 		$10K Sell
1,600
-15,600
-91% -$75.9K ﹤0.01% 7288
2025
Q1 		$60K Sell
17,200
-2,200
-11% -$7.83K ﹤0.01% 5586
2024
Q4 		$73K Sell
19,400
-221,500
-92% -$1.04M ﹤0.01% 5477
2024
Q3 		$780K Sell
240,900
-292,900
-55% -$658K ﹤0.01% 3151
2024
Q2 		$1.01M Sell
533,800
-289,000
-35% -$560K ﹤0.01% 2895
2024
Q1 		$2.34M Buy
822,800
+703,000
+587% +$9.19M ﹤0.01% 2253
2023
Q4 		$1.76M Buy
119,800
+2,300
+2% +$35.3K ﹤0.01% 2468
2023
Q3 		$2.15M Buy
117,500
+35,700
+44% +$755K ﹤0.01% 2012
2023
Q2 		$1.76M Buy
81,800
+32,600
+66% +$880K ﹤0.01% 2070
2023
Q1 		$1.44M Sell
49,200
-8,600
-15% -$299K ﹤0.01% 2236
2022
Q4 		$2.13M Sell
57,800
-44,700
-44% -$1.59M ﹤0.01% 1813
2022
Q3 		$2.88M Buy
102,500
+96,900
+1,730% +$2.42M ﹤0.01% 1652
2022
Q2 		$107K Buy
5,600
+1,600
+40% +$19K ﹤0.01% 5483
2022
Q1 		$51K Buy
+4,000
New +$90.3K ﹤0.01% 7086

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Simplex Trading's AMLX Position: Q1 2026 in Review

Simplex Trading sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2026, closing a stake of 3,727 shares — an estimated $52.4K sold.

Simplex Trading first reported a position in AMLX in Q1 2022 and held it in 13 quarters. The position peaked at $3.28M in Q3 2022. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Simplex Trading reported no remaining Amylyx Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,727 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $52.4K.
  • Simplex Trading first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 13 quarters.
  • Simplex Trading's Amylyx Pharmaceuticals position peaked at $3.28M in Q3 2022.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.